Spectrum Pharmaceuticals, Inc. (Spectrum) is a commercial stage biopharmaceutical company, engaged in developing and commercializing therapies with a focus primarily in the areas of hematology-oncology and urology. Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) achieved its new 52 week high price of $15.22 where it was opened at $14.60 up 0.11 points or +0.76% by closing at $14.62.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

?While we recognize that such filings are not unusual given that FUSILEV has reached significant revenue milestones, we are confident that our exclusivity position is strong," stated Rajesh C. Shrotriya, MD., Chairman, Chief Executive Officer, and President of Spectrum Pharmaceuticals.

Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) achieved its new 52 week high price of $12.88 where it was opened at $12.56 down -0.20 points or -1.60% by closing at $12.30. SPPI transacted shares during the day were over 1.72 million shares however it has an average volume of 1.09 million shares.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6507